Riskpilot← Back to searchSign inGet full accessFSK Vascular Oy
OYDissolvedY-tunnus 3102452-3A -BMedical specialists activities · NACE 8622Est. 20190 employees
Revenue 2025
EUR 49K
+65% vs 2024
EBITDA margin
66.4%
+84% vs 2024
Equity ratio
92.7%
Financial strength
Net profit 2025
EUR 27K
+89% vs 2024
| Revenue | EUR 49K | +65% |
| EBITDA | EUR 32K | +84% |
| Net profit | EUR 27K | +89% |
| Total assets | EUR 81K | +54% |
| Equity | EUR 75K | +43% |
| Employees | 0 | — |
Legal name
FSK Vascular Oy
Y-tunnus number
3102452-3
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
29. marraskuuta 2019
Share capital
EUR 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana ovat lääkäri- ja terveydenhoitopalvelut, sekä niihin liittyvät valmennus-, koulutus-, markkinointi- ja neuvontapalvelut sekä kustannustoiminta ja muu liiketoiminta Suomessa ja ulkomailla. Yhtiön toimialana on arvopaperikauppa sekä osakkeiden ja kiinteistöjen omistaminen, hallinta, vuokraus ja kauppa.
Address
A -B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 28 | 30 | 30 | 30 | 49 |
| Staff expenses | −1 | −2 | −2 | −2 | −2 |
| EBITDA | 16 | 19 | 18 | 18 | 32 |
| Depreciation & amort. | — | — | −0 | −0 | −2 |
| EBIT | 16 | 19 | 18 | 18 | 30 |
| Net financials | −0 | −0 | −0 | 0 | 3 |
| Profit before tax | 16 | 19 | 18 | 18 | 33 |
| Tax | 3 | 4 | 4 | 4 | 7 |
| Net profit | 13 | 15 | 14 | 14 | 27 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 18 | 34 | 42 | 53 | 81 |
| Equity | 15 | 30 | 42 | 53 | 75 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 3 | 4 | 1 | 0 | 6 |
| Total debt | 3 | 4 | 1 | 0 | 6 |
EBITDA margin
66.4%
This company
15.8%
Market median
+320% vs market
20212025
Equity ratio
92.7%
This company
38.2%
Market median
+143% vs market
20212025
Return on equity
35.5%
This company
18.4%
Market median
+93% vs market
20212025
Net profit margin
54.7%
This company
8.1%
Market median
+575% vs market
20212025
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
20212025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JP Chief Executive Officer | Chief Executive Officer | 2019 |
JC Deputy Member | Deputy Member | 2019 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FSK Vascular Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Patrick Vilhelm Björkman | Chief Executive Officer | 0 companies |
| Julia Charlotta Ruth | Deputy Member | 0 companies |